EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Therapy Targeted to the NLRP3 Inflammasome in Chronic Kidney Disease

Yong Ji, Hu Hua, Zhanjun Jia, Aihua Zhang, Guixia Ding

Kidney Diseases · 30.05.2024 · 10 (5) · 369-383

DOI: 10.1159/000539496 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Kidney Diseases, online erschienen am 30.05.2024. Verfasst von Yong Ji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: The NLRP3 inflammasome is a cytoplasmic polymeric protein complex composed of the cytoplasmic sensor NLRP3, the apoptosis-related spot-like protein ASC, and the inflammatory protease caspase-1. NLRP3 activates and releases IL-1β through classical pathways, and IL-18 mediates inflammation and activates gasdermin-D protein to induce cellular pyroptosis. Numerous studies have also emphasized the non-classical pathway activated by the NLRP3 inflammasome in chronic kidney disease (CKD) and the inflammasome-independent function of NLRP3. Summary: The NLRP3-targeting inflammasome and its associated pathways have thus been widely studied in models of CKD treatment, but no drug that targets NLRP3 has thus far been approved for the treatment of CKD. Key Messages: We herein reviewed the current interventional methods for targeting the NLRP3 inflammasome in various CKD models, analyzed their underlying mechanisms of action, classified and compared them, and discussed the advantages and follow-up directions of various interventional methods. This review therefore provides novel ideas and a reference for the development of targeted NLRP3-inflammasome therapy in CKD.

Schlagwörter

Stichwörter der Autor:innen

Chronic kidney diseaseMCC950NLRP3 inflammasomeTargeted therapy

Autor:innen und Institutionen

  • Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Jiangsu Key Laboratory of Pediatrics, Nanjing Medical University, Nanjing, China.

Zitieren

APA

Ji, Y., Hua, H., Jia, Z., Zhang, A., & Ding, G. (2024). Therapy Targeted to the NLRP3 Inflammasome in Chronic Kidney Disease. Kidney Diseases, 10(5), 369-383. https://doi.org/10.1159/000539496

Vancouver

Ji Y, Hua H, Jia Z, Zhang A, Ding G. Therapy Targeted to the NLRP3 Inflammasome in Chronic Kidney Disease. Kidney Diseases. 2024;10(5):369-383. doi:10.1159/000539496

BibTeX
@article{Ji2024,
  author = {Ji, Yong and Hua, Hu and Jia, Zhanjun and Zhang, Aihua and Ding, Guixia},
  title = {Therapy Targeted to the NLRP3 Inflammasome in Chronic Kidney Disease},
  journal = {Kidney Diseases},
  year = {2024},
  volume = {10},
  number = {5},
  pages = {369--383},
  doi = {10.1159/000539496}
}
Kostenlos starten →